1. Market Research
  2. > Business Services
  3. > Research and Development Market Trends
  4. > RFS Pharma, LLC - Product Pipeline Review - 2014

RFS Pharma, LLC - Product Pipeline Review - 2014

  • December 2014
  • -
  • Global Markets Direct
  • -
  • 27 pages

RFS Pharma, LLC - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘RFS Pharma, LLC - Product Pipeline Review - 2014’, provides an overview of the RFS Pharma, LLC’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of RFS Pharma, LLC’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of RFS Pharma, LLC including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of RFS Pharma, LLC’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the RFS Pharma, LLC’s pipeline products

Reasons to buy

- Evaluate RFS Pharma, LLC’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of RFS Pharma, LLC in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the RFS Pharma, LLC’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of RFS Pharma, LLC and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of RFS Pharma, LLC
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of RFS Pharma, LLC and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table Of Contents

RFS Pharma, LLC - Product Pipeline Review - 2014
Table of Contents

RFS Pharma, LLC Snapshot 4
RFS Pharma, LLC Overview 4
Key Information 4
Key Facts 4
RFS Pharma, LLC - Research and Development Overview 5
Key Therapeutic Areas 5
RFS Pharma, LLC - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Pipeline Products - Out-Licensed Products 9
Out-Licensed Products/Combination Treatment Modalities 10
RFS Pharma, LLC - Pipeline Products Glance 11
RFS Pharma, LLC - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
RFS Pharma, LLC - Drug Profiles 13
amdoxovir 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
RS-1137 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
RS-1142 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
RS-1145 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
RS-930 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
RS-961 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
RFS Pharma, LLC - Pipeline Analysis 20
RFS Pharma, LLC - Pipeline Products by Target 20
RFS Pharma, LLC - Pipeline Products by Molecule Type 21
RFS Pharma, LLC - Pipeline Products by Mechanism of Action 22
RFS Pharma, LLC - Recent Pipeline Updates 23
RFS Pharma, LLC - Dormant Projects 24
RFS Pharma, LLC - Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
Coverage 26
Secondary Research 26
Primary Research 26
Expert Panel Validation 26
Contact Us 27
Disclaimer 27

List of Tables

RFS Pharma, LLC, Key Information 4
RFS Pharma, LLC, Key Facts 4
RFS Pharma, LLC - Pipeline by Indication, 2014 6
RFS Pharma, LLC - Pipeline by Stage of Development, 2014 7
RFS Pharma, LLC - Monotherapy Products in Pipeline, 2014 8
RFS Pharma, LLC - Out-Licensed Products in Pipeline, 2014 9
RFS Pharma, LLC - Out-Licensed Products/ Combination Treatment Modalities, 2014 10
RFS Pharma, LLC - Preclinical, 2014 11
RFS Pharma, LLC - Discovery, 2014 12
RFS Pharma, LLC - Pipeline by Target, 2014 20
RFS Pharma, LLC - Pipeline by Molecule Type, 2014 21
RFS Pharma, LLC - Pipeline Products by Mechanism of Action, 2014 22
RFS Pharma, LLC - Recent Pipeline Updates, 2014 23
RFS Pharma, LLC - Dormant Developmental Projects,2014 24

List of Figures

RFS Pharma, LLC - Pipeline by Top 10 Indication, 2014 6
RFS Pharma, LLC - Pipeline by Stage of Development, 2014 7
RFS Pharma, LLC - Monotherapy Products in Pipeline, 2014 8
RFS Pharma, LLC - Pipeline by Top 10 Molecule Type, 2014 21

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016

Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016’, provides in depth analysis on Integrin Alpha 7 (ITGA7) ...

Pulmonary Fibrosis - Pipeline Review, H2 2016

Pulmonary Fibrosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Pulmonary Fibrosis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H2 2016’, provides an overview of the Pulmonary Fibrosis pipeline landscape. ...

Cognitive Impairment - Pipeline Review, H2 2016

Cognitive Impairment - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Cognitive Impairment - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H2 2016’, provides an overview of the Cognitive Impairment pipeline landscape. ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.